Current approved therapeutic strategies for IPF and LC treatment

By A Mystery Man Writer

Clinical applications of mesenchymal stromal cell-based therapies for pulmonary diseases: An Update and Concise Review

Role of vitamin D3 in selected pulmonary diseases with particular emphasis on lung fibrosis

Valentina MASCIALE, PostDoc Position

Massimo DOMINICI Università degli Studi di Modena e Reggio

Giorgia GUAITOLI, Resident

34335 PDFs Review articles in CIGARETTE SMOKING

Tissue fibrosis induced by radiotherapy: current understanding of the molecular mechanisms, diagnosis and therapeutic advances, Journal of Translational Medicine

Small-molecule-mediated OGG1 inhibition attenuates pulmonary inflammation and lung fibrosis in a murine lung fibrosis model

Inhibition of LPA-LPAR1 and VEGF-VEGFR2 signaling in IPF

IJMS, Free Full-Text

Inhibition of LPA-LPAR1 and VEGF-VEGFR2 signaling in IPF

©2016-2024, doctommy.com, Inc. or its affiliates